Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaspect Study – An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia: Complete Statistical AnalysisIndependent statistical analysis of Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- VASSTIndependent statistical analysis of An Exploratory Clinical Study on a Variable Speed and Sensing Treadmill System (VASST) for Hemiparetic Gait Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- VASTIndependent statistical analysis of Video Assisted Speech Technology to Enhance Motor Planning for Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04764539).
- VASTIndependent statistical analysis of Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05319561).
- VAST-DComplete statistical analysis of VAST-D, the phase 3 randomized trial of switching to bupropion-SR versus augmentation with bupropion-SR or aripiprazole for major depressive disorder, including remission, response, relapse, statistical methodology, safety, and…
- VATIndependent statistical analysis of Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- VAULTIndependent statistical analysis of Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01950741).
- VAX-002Independent statistical analysis of Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: Complete Statistical AnalysisIndependent statistical analysis of VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05570630).
- VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: Complete Statistical AnalysisIndependent statistical analysis of VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03220737).
- VB-111 in Surgically Accessible Recurrent/Progressive GBM: Complete Statistical AnalysisIndependent statistical analysis of VB-111 in Surgically Accessible Recurrent/Progressive GBM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04406272).
- VBXFLEXIndependent statistical analysis of A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VC01-103Independent statistical analysis of A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VEC-162 Study in Adult Patients With Primary Insomnia: Complete Statistical AnalysisIndependent statistical analysis of VEC-162 Study in Adult Patients With Primary Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00548340).
- VECTORIndependent statistical analysis of Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VECTORIndependent statistical analysis of Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VECTORIndependent statistical analysis of Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Vector Efficacy Cross-Over Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Vector Efficacy Cross-Over Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04263532).
- Vector Engineering Clinical: Complete Statistical AnalysisIndependent statistical analysis of Vector Engineering Clinical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04725500).
- VEGAIndependent statistical analysis of Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02396316).
- VEGA-1Independent statistical analysis of Norepinephrine vs Phenylephrine During General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789330).
- VEGA-2Independent statistical analysis of Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia: primary endpoint results, effect estimate with…
- VEGA-3Independent statistical analysis of Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide: Complete Statistical AnalysisIndependent statistical analysis of VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VELIAIndependent statistical analysis of Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal…
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect…
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04067011).
- VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation: Complete Statistical AnalysisIndependent statistical analysis of VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VELOCITY: An Anthrax Vaccine Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of VELOCITY: An Anthrax Vaccine Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03877926).
- VELVETIndependent statistical analysis of A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor…
- VeLVETIndependent statistical analysis of Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02691936).
- Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma: Complete Statistical AnalysisIndependent statistical analysis of Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vemurafenib and TIL Therapy for Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vemurafenib and TIL Therapy for Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354690).
- Venclose RF Ablation System for the Treatment of IPVs: Complete Statistical AnalysisIndependent statistical analysis of Venclose RF Ablation System for the Treatment of IPVs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04386785).
- Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL: Complete Statistical AnalysisIndependent statistical analysis of Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03045328).
- Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VENICEIndependent statistical analysis of Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VENICE IIIndependent statistical analysis of A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer…
- Venlafaxine 25 mg Tablets Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Venlafaxine 25 mg Tablets Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00834249).
- Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01260896).
- Ventilation Strategy During General Anesthesia for Orthopedic Surgery: A Quality Improvement Project: Complete Statistical AnalysisIndependent statistical analysis of Ventilation Strategy During General Anesthesia for Orthopedic Surgery: A Quality Improvement Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ventilation Using a Bag Valve Mask With Supplemental External Handle: Complete Statistical AnalysisIndependent statistical analysis of Ventilation Using a Bag Valve Mask With Supplemental External Handle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02800213).
- VENTURA-1Independent statistical analysis of A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy: primary endpoint results,…
- VENTUREIndependent statistical analysis of Vitamin D to ENhance TraUma REcovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05458024).
- VENUSIndependent statistical analysis of Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- VEPSCIndependent statistical analysis of Vaccination Education Through Pharmacists and Senior Centers (VEPSC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03239665).